Singular Genomics Systems, Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Singular Genomics Systems, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Singular Genomics Systems, Inc. Return On Equity for the quarter ending June 30, 2024 was -54.7 %, a 44.6% decline year-over-year.
  • Singular Genomics Systems, Inc. annual Return On Equity for 2023 was -45.3 %, a 43.7% decline from 2022.
  • Singular Genomics Systems, Inc. annual Return On Equity for 2022 was -31.6 %, a 21.6% increase from 2021.
  • Singular Genomics Systems, Inc. annual Return On Equity for 2021 was -40.3 %, a 158% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -54.7 -16.9 -44.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -51.1 -16.7 -48.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -45.3 -13.8 -43.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -40.4 -11.2 -38.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.8 -12.2 -47.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.4 -6.18 -21.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -31.6 +8.71 +21.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -29.2 +28.3 +49.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -25.6 +127 +83.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -28.2 -116 -132% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.3 -109 -158% Oct 1, 2021 Dec 31, 2021
Q3 2021 -57.5 Jul 1, 2021 Sep 30, 2021
Q2 2021 -153 Apr 1, 2021 Jun 30, 2021
Q1 2021 87.8 Jan 1, 2021 Mar 31, 2021
Q4 2020 69 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.